Prenatal Programming of Childhood Obesity and Cardio Metabolic Disorders
Launched by HELSINKI UNIVERSITY CENTRAL HOSPITAL · Feb 3, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how certain health conditions during pregnancy might affect the health of children as they grow up. Specifically, researchers want to understand how being overweight, having high blood pressure, or developing diabetes during pregnancy can influence a child's weight and overall health from ages 11 to 17. The study involves mothers and their children who were part of earlier studies, and it will include various tests to check the children's heart and metabolic health.
To participate, mothers must have been involved in the earlier PREDO or RADIEL studies when they were pregnant. There are no specific exclusions mentioned, so if you meet the inclusion criteria, you may be eligible. During the study visits, both mothers and their children will undergo health assessments, and this research aims to provide important insights that could help prevent obesity and related health issues in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all mothers participated originally in the PREDO or the RADIEL studies during pregnancy and with delivery during this index pregnancy
- Exclusion Criteria:
- • -
About Helsinki University Central Hospital
Helsinki University Central Hospital (HUCH) is a leading academic medical institution in Finland, dedicated to advancing healthcare through innovative research and clinical excellence. As a pivotal sponsor of clinical trials, HUCH integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations between researchers, healthcare professionals, and patients. The hospital is committed to enhancing patient outcomes and contributing to the global body of medical knowledge by conducting high-quality, ethically sound clinical studies across a diverse range of therapeutic areas. With a strong emphasis on education and training, HUCH plays a vital role in shaping the next generation of healthcare leaders and researchers.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials